Carregant...
RGS16 promotes glioma progression and serves as a prognostic factor
BACKGROUND: RGS protein family members have recently became new potentially promising therapeutic targets in many cancers. However, as a key member of RGS family, RGS16 has seldom been studied in glioma. The present study was designed to investigate the prognostic value and biological function of RG...
Guardat en:
| Publicat a: | CNS Neurosci Ther |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7366748/ https://ncbi.nlm.nih.gov/pubmed/32319728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13382 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|